JP Morgan Moves Alexion Pharma To Overweight, Says Strensiq And Kanuma Are $1.7B Opportunity
July 27, 2015 at 08:18 AM EDT
In a report published Monday, JP Morgan analyst Anupam Rama upgraded the rating on Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) from ...